Organigram Global Inc.
OGI
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $162.6M
$1.16
▼ -1.28%
P/E
7.70
Mkt Cap
$162.6M
52-Wk Range
$0.85–$2.24
52-Week Range
$0.85 - $2.24
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 29.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Above-average volatility (beta 1.8).
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Strong
+9.0% over 3m
Quality
Loss-making
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying OGI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 11, 2026
Reported EPS of -$0.05 vs -$0.01 consensus (-400.0% surprise). Revenue of $74.5M vs $68.2M expected (+9.2%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-400.0%
Revenue trend · last 1Q
—
Q1 26
$63.5M
Margins · last 1Q
Profit
31.4%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How OGI stacks vs Drug Manufacturers - Specialty & Generic
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.